Compare AURA & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AURA | CINT |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | United States | Brazil |
| Employees | N/A | 7993 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.5M | 478.1M |
| IPO Year | 2021 | 2021 |
| Metric | AURA | CINT |
|---|---|---|
| Price | $7.52 | $3.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $20.00 | $7.35 |
| AVG Volume (30 Days) | ★ 699.3K | 100.2K |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.69 |
| Revenue Next Year | N/A | $11.28 |
| P/E Ratio | ★ N/A | $17.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $3.51 |
| 52 Week High | $9.54 | $6.39 |
| Indicator | AURA | CINT |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 34.47 |
| Support Level | $5.24 | N/A |
| Resistance Level | $9.54 | $5.01 |
| Average True Range (ATR) | 0.54 | 0.22 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 21.31 | 22.37 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.